|
Tolvaptan |
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one |
160129-45-3 |
|
|
7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one |
137982-91-3 |
|
|
|
1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |
137977-97-0 |
|
|
|
2-Methyl-4-(2-methylbenzoylamino)benzoic acid |
317374-08-6 |
|
Route-relevant purity — Each lot is released against verified specifications including HPLC purity (typically 98–99%), appearance, and identity confirmation. For the N-2 intermediate (137977-97-0), impurity profiling is supported with documented maximum single impurity ≤0.1% .
Documentation ready for your filing — Certificate of Analysis (COA) with batch-specific data, Safety Data Sheet (SDS), and customs documentation with every shipment. CMC-ready documentation packages are available for Tolvaptan N-2 intermediate .
Scalable quantities — From milligram reference standards for analytical method development to kilogram and multi-kilogram batches for process validation and commercial production.
Technical support — Our process chemistry team can advise on route selection, impurity mapping, and analytical strategies for tolvaptan-related compounds.
Send us your target intermediate and specifications — we will respond promptly with availability, pricing, and lead times.
